跳至主要内容
临床试验/EUCTR2008-005356-25-ES
EUCTR2008-005356-25-ES进行中(未招募)1 期

ong-term, open-label, flexible-dose, extension study of vortioxetine in child and adolescent patients with Major Depressive Disorder (MDD) from 7 to 18 years of age

H. Lundbeck A/S0 个研究点目标入组 850 人开始时间: 2016年4月20日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
850

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - The patient is a male or female child aged > =7 and <12 years or an adolescent aged > =12 and <=18 years in the lead-in study (12709A and 12710A).
  • - The patient must have completed Study 12709A or 12710A (Visit 12, Completion Visit) immediately prior to enrolment into this extension study.
  • - The patient had a primary diagnosis of MDD at entry in study 12709A or 12710A, diagnosed according to DSM-5?.
  • - The patient is indicated for long-term treatment with vortioxetine according to the clinical opinion of the Investigator.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 850
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - The patient has been diagnosed with another psychiatric disorder (for example mania, bipolar disorder, schizophrenia or any psychotic disorder) during study 12709A or 12710A.
  • - The patient has an attention-deficit/hyperactivity disorder (ADHD) that requires a pharmacological treatment other than a stimulant medication.

研究者

相似试验

进行中(未招募)
1 期
A study to evaluate the long-term safety and tolerability of a product named vortioxetine (used in depression) in children and adolescents.MedDRA version: 21.1Level: PTClassification code 10057840Term: Major depressionSystem Organ Class: 10037175 - Psychiatric disordersMajor Depressive Disorder
EUCTR2008-005356-25-DEH. Lundbeck A/S696
进行中(未招募)
1 期
A study to evaluate the long-term safety and tolerability of a product named vortioxetine (used in depression) in children and adolescents.MedDRA version: 19.0Level: PTClassification code 10057840Term: Major depressionSystem Organ Class: 10037175 - Psychiatric disordersMajor Depressive Disorder
EUCTR2008-005356-25-FIH. Lundbeck A/S850
进行中(未招募)
1 期
A study to evaluate the long-term safety and tolerability of a product named vortioxetine (used in depression) in children and adolescents.MedDRA version: 20.0Level: PTClassification code 10057840Term: Major depressionSystem Organ Class: 10037175 - Psychiatric disordersMajor Depressive Disorder
EUCTR2008-005356-25-LVH. Lundbeck A/S850
进行中(未招募)
1 期
A study to evaluate the long-term safety and tolerability of a product named vortioxetine (used in depression) in children and adolescents.MedDRA version: 19.0Level: PTClassification code 10057840Term: Major depressionSystem Organ Class: 10037175 - Psychiatric disordersMajor Depressive Disorder
EUCTR2008-005356-25-ITH. Lundbeck A/S662
进行中(未招募)
1 期
A study to evaluate the long-term safety and tolerability of a product named vortioxetine (used in depression) in children and adolescents.Major Depressive Disorder
EUCTR2008-005356-25-HUH. Lundbeck A/S850